Early Decline in Left Ventricular Ejection Fraction Can Predict Trastuzumab-Related Cardiotoxicity in Patients with Breast Cancer: A Study Using 13 Years of Registry Data
Eun Kyoung Kim, Jinhyun Cho, Ji-Yeon Kim, Sung-A Chang, Sung-Ji Park, Jin Oh Choi, Sang Chol Lee, Jin Seok Ahn, Seung Woo Park, Young-Hyuck Im, Eun Seok Jeon, Yeon Hee Park
Cancer Res Treat. 2019;51(2):727-736. Published online 2018 Sep 4 DOI: https://doi.org/10.4143/crt.2018.262
Citations to this article as recorded by 
ABSDELL Model: Development and Internal Validation of a Risk Prediction Model of LVEF Decline in Breast Cancer Patients Treated With Trastuzumab
Xin Liu, Liyuan Tao, Mopei Wang, Haiyan Li, Weixian Xu
Clinical Breast Cancer.2023; 23(1): 23. CrossRef
New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review
Alexia Alexandraki, Elisavet Papageorgiou, Marina Zacharia, Kalliopi Keramida, Andri Papakonstantinou, Carlo M. Cipolla, Dorothea Tsekoura, Katerina Naka, Ketti Mazzocco, Davide Mauri, Manolis Tsiknakis, Georgios C. Manikis, Kostas Marias, Yiola Marcou, E
Cancers.2023; 15(13): 3290. CrossRef
Guidelines in Cardio-Oncology: The Balance Between Evidence and Expert Opinion
Douglas J. Leedy, Marta Alhama-Belotto, William R. Gwin, Ruchi Kapoor, Elina Minami, Eric J. Chow, Richard K. Cheng
Current Treatment Options in Cardiovascular Medicine.2023; 25(11): 639. CrossRef
Cardiovascular adverse events of antineoplastic monoclonal antibodies among cancer patients: real-world evidence from a tertiary healthcare system
Abdulrazaq S. Al-Jazairi, Nahlah Bahammam, Dhai Aljuaid, Lama Almutairi, Shroog Alshahrani, Norah Albuhairan, Peter M. B. Cahusac, Ghazwa B. Korayem
Cardio-Oncology.2023;[Epub] CrossRef
Lessons learnt in the first year of an Australian pediatric cardio oncology clinic
Claudia Toro, Ben Felmingham, Mangesh Jhadav, David S. Celermajer, Andre La Gerche, John O’Sullivan, Sanjeev Kumar, Marion K. Mateos, Joy Fulbright, Dinisha Govender, Lane Collier, Michael Cheung, David D. Eisenstat, Peter W. Lange, Julian Ayer, David A.
Cardio-Oncology.2023;[Epub] CrossRef
Deceleration capacity of heart rate predicts trastuzumab‐related cardiotoxicity in patients with HER2‐positive breast cancer: A prospective observational study
Yanying Feng, Zhenhua Qin, Zhijun Yang
Journal of Clinical Pharmacy and Therapeutics.2021; 46(1): 93. CrossRef
Vascular and Cardiac Prognostic Determinants in Patients with Gynecological Cancers: A Six-Year Follow-up Study
Pietro Scicchitano, Marco Tucci, Gabriella Ricci, Michele Gesualdo, Santa Carbonara, Giuseppe Totaro, Annagrazia Cecere, Rosa Carbonara, Francesca Cortese, Vera Loizzi, Gennaro Cormio, Ettore Cicinelli, Marco Matteo Ciccone
Applied Sciences.2021; 11(13): 6091. CrossRef
Cardiotoxicity Associated with Chemotherapy Used in Gastrointestinal Tumours
Liliana Maria Radulescu, Dan Radulescu, Tudor-Eliade Ciuleanu, Dana Crisan, Elena Buzdugan, Dragos-Mihai Romitan, Anca Dana Buzoianu
Medicina.2021; 57(8): 806. CrossRef
Successful Use of Digoxin for Trastuzumab-related Cardiotoxicity to Facilitate Breast Surgery in a Patient with Metastatic Breast Cancer
Tsuyoshi SHIGA, Takako KAMIO, Kenta UTO, Kotaro ARAI
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics .2021; 52(4): 101. CrossRef
Treatment with Beta-Blockers and ACE-Inhibitors in Breast Cancer Patients Receiving Adjuvant Trastuzumab-Based Therapy and Developing Mild Cardiac Toxicity: A Prospective Study
Elena Geuna, Pasquale Lombardi, Rossella Martinello, Davide Garino, Alessandro Bonzano, Danilo Galizia, Annamaria Nuzzo, Paola Berchialla, Paolo Becco, Monica Mangioni, Lorena De Zarlo, Filippo Montemurro
Cancers.2020; 12(2): 327. CrossRef
A Prospective Study About Trastuzumab-induced Cardiotoxicity in HER2-positive Breast Cancer
Wala Ben Kridis, Syrine Sghaier, Salma Charfeddine, Nabil Toumi, Jamel Daoud, Samir Kammoun, Afef Khanfir
American Journal of Clinical Oncology.2020; 43(7): 510. CrossRef
Examining Cardiotoxicity With HER2 Therapies
Neelima Denduluri
JACC: CardioOncology.2020; 2(2): 176. CrossRef
Determinants of left ventricular ejection fraction and a novel method to improve its assessment of myocardial contractility
Manuel Ignacio Monge García, Zhongping Jian, Jos J. Settels, Charles Hunley, Maurizio Cecconi, Feras Hatib, Michael R. Pinsky
Annals of Intensive Care.2019;[Epub] CrossRef
The Role of Echocardiography in Cardio-oncology Patients: Contemporary Indications and Future Directions
Saiuj Bhat, Nestor Gahungu, Paaladinesh Thavendiranathan, Girish Dwivedi
Current Cardiovascular Imaging Reports.2019;[Epub] CrossRef
Novel HER2-Targeting Antibody-Drug Conjugates of Trastuzumab Beyond T-DM1 in Breast Cancer: Trastuzumab Deruxtecan(DS-8201a) and (Vic-)Trastuzumab Duocarmazine (SYD985)
Zhuyu Xu, Dandan Guo, Zhongliang Jiang, Rongsheng Tong, Peidu Jiang, Lan Bai, Lu Chen, Yuxuan Zhu, Chun Guo, Jianyou Shi, Dongke Yu
European Journal of Medicinal Chemistry.2019; 183: 111682. CrossRef